Quick Heal Technologies Limited

NSE:QUICKHEAL.NS

655.4 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q4
Revenue 702.9800.3819.2783.6514.4492.76681,009.4610.81,037.15796.161,037.85547.841,052.94698.75844.13734.62642.54657.07985.77576860.01667.051,091.32530.881,186.92642.441,050.63303.16910.83545.51,067.9475.51,123.7554.1857.9485.21,041.07
Cost of Revenue 484.7490.8458.5437.7403.414.225.138161,420.927.0139.9310.46114.721.430.4924.49111.5216.4736.8418.04114.3934.3253.7323.11166.0435.4550.8818.11048.487.345.51.1466.374.154.157.9
Gross Profit 218.2309.5360.7345.9111478.5642.9971.4594.8-383.75769.15997.92537.38938.24677.35813.64710.13531.02640.6948.93557.96745.62632.731,037.59507.771,020.88606.99999.75285.05910.83497.1980.64301,122.56487.8783.8431.1983.17
Gross Profit Ratio 0.310.3870.440.4410.2160.9710.9620.9620.974-0.370.9660.9620.9810.8910.9690.9640.9670.8260.9750.9630.9690.8670.9490.9510.9560.860.9450.9520.9410.9110.9180.9040.9990.880.9140.8880.944
Reseach & Development Expenses 345337348330318.5307.8328.6304.7278.2270.9213.04201.02193.76461.63159.06160.24142.33400.25125.18137.17137.9413.67131.83139.52143.91412.29133.63136.48144.37479.9157.3163.8158.8436147.3149.1139.60
General & Administrative Expenses 0000000000000365.16000262.75000-311.95120.92136.11121.13-296.25128.16122.57127.08433.4142.8135.7154.9328.6118.6105.3104.7181.66
Selling & Marketing Expenses 00000343000276.8000226.2000314.08000-188.35172.9165.48153.49-242.69230.52145.88174.15248.87165.3143.3150.2149.15200.1138.1139.3206.79
SG&A -124.8240.9-103.5-93.8393.3-4724.2-11.6-65.1-20.617.75-6-36.01591.36289.82280.99261.53576.83246.96255.1266.32-500.3293.82301.59274.62-538.94358.68268.45301.23376.42308.1279305.1423.43318.7243.4244388.45
Other Expenses 50.668.241.556.947.3100.634.75432-99.8336.3136.5162.51-134.4562.8758.2563.15-167.9475.773.3884.46-212.6690.5886.8564.09-79.5352.2357.2855.35000000000
Operating Expenses 220.2240.9276.9268.7291.1677.6798.3729623.8-688.39609.78576.46526.35414.02562.29471.57435.28508.73462.26526.65481.35411.64485.44501.27477.75431.75560.51472.54509.81808.92464.4447.3503.4648.74513.9423.2421.9641.69
Operating Income -268.683.877.2-180.1-199.1-155.4242.4-29302.94159.37421.4611.03524.22115.06342.07274.8522.29178.34422.2876.61333.98147.29536.3230.02589.1346.48527.21-224.76289.84-44.1460.1-107.9495.36-38.5334.8-9.5323.88
Operating Income Ratio -0.0030.0860.1020.099-0.35-0.404-0.2330.24-0.0470.2920.20.4060.020.4980.1650.4050.3740.0350.2710.4280.1330.3880.2210.4910.0570.4960.0720.502-0.7410.318-0.0810.431-0.2270.441-0.0690.39-0.020.311
Total Other Income Expenses Net 50.166.941.556.947.3100.634.7543256.6735.9736.5162.5120.962.8758.2563.1580.0575.773.3884.4681.0690.5886.8564.09131.2452.2357.2955.3556.2776.873.234.541.9112.425.818.717.6
Income Before Tax 48.1135.5125.3134.1-132.8-98.5-120.7296.43359.61195.34457.9773.54545.12177.93400.32338102.34254.04495.66161.07415.04237.87623.1794.11720.3798.71584.5-169.41346.1132.7533.3-73.4537.27-26.1360.69.2341.48
Income Before Tax Ratio 0.0680.1690.1530.171-0.258-0.2-0.1810.2940.0050.3470.2450.4410.1340.5180.2550.4740.460.1590.3870.5030.280.4830.3570.5710.1770.6070.1540.556-0.5590.380.060.499-0.1540.478-0.0470.420.0190.328
Income Tax Expense 7.8-4.924.75.1-5.2-32-27.874.81.278.6952.81111.6911.71147.8643.32111.9788.4222.4176.19128.3142.09137.5779.25202.1432.99228.5932.18199.7-56.36124.1416.5184.518.7172.693.8120.64.9110.34
Net Income 40.3140.4100.6129-127.6-66.5-92.9221.61.8280.92142.87346.2861.83397.26134.61288.35249.5879.93177.85367.35118.98277.47158.62421.0361.12491.7866.53384.8-113.05221.9716.2348.8-54.7364.58-29.92404.3231.14
Net Income Ratio 0.0570.1750.1230.165-0.248-0.135-0.1390.220.0030.2710.1790.3340.1130.3770.1930.3420.340.1240.2710.3730.2070.3230.2380.3860.1150.4140.1040.366-0.3730.2440.030.327-0.1150.324-0.0540.280.0090.222
EPS 0.752.631.892.43-2.4-1.25-1.73.820.0314.842.475.390.976.22.14.493.891.252.775.721.74.322.255.970.877.660.955.48-1.613.160005.8403.9303.73
EPS Diluted 0.742.571.862.42-2.4-1.25-1.73.810.034.832.455.360.976.22.094.493.891.252.775.721.74.322.255.970.877.660.955.48-1.613.170005.8403.9303.73
EBITDA 25.9100.4116.2109.7-150.8-161.8-113.7283.810.5350.41204.8463.0852.01488.43164.63390.86321.36-19.35232.25477.58128.24390.3207.08596.4889.24658.38114.68594.82-160.55345.83.665507.865-33.9543.128-10.219391.56541374.38
EBITDA Ratio 0.0370.1250.1420.14-0.293-0.328-0.170.2810.0170.3380.2570.4460.0950.4640.2360.4630.437-0.030.3530.4840.2230.4540.310.5470.1680.5550.1790.566-0.530.380.0070.476-0.0710.483-0.0180.4560.0850.36